XML 69 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Ordinary Shares
Deferred Shares
Deferred B Shares
Deferred C Shares
Common shares
Ordinary Shares
Common shares
Deferred Shares
Common shares
Deferred B Shares
Common shares
Deferred C Shares
Additional Paid in Capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021           90,907,830 34,425 88,893,548 1      
Beginning balance at Dec. 31, 2021 $ 313,320         $ 4 $ 0 $ 118 $ 0 $ 843,108 $ (8,570) $ (521,340)
Stockholders' Equity                        
Share-based compensation expense 8,599                 8,599    
Vesting of restricted stock (in shares)           76,804            
Vesting of restricted stock 0                      
Exercise of share options (in shares)           147,722            
Exercise of share options 117                 117    
Unrealized loss on foreign currency translation (38,994)                   (38,994)  
Net loss (121,888)                     (121,888)
Ending balance (in shares) at Sep. 30, 2022           91,132,356 34,425 88,893,548 1      
Ending balance at Sep. 30, 2022 161,154         $ 4 $ 0 $ 118 $ 0 851,824 (47,564) (643,228)
Beginning balance (in shares) at Jun. 30, 2022           90,909,783 34,425 88,893,548 1      
Beginning balance at Jun. 30, 2022 214,521         $ 4 $ 0 $ 118 $ 0 848,370 (33,510) (600,461)
Stockholders' Equity                        
Share-based compensation expense 3,337                 3,337    
Vesting of restricted stock (in shares)           76,804            
Vesting of restricted stock 0                      
Exercise of share options (in shares)           145,769            
Exercise of share options 117                 117    
Unrealized loss on foreign currency translation (14,054)                   (14,054)  
Net loss (42,767)                     (42,767)
Ending balance (in shares) at Sep. 30, 2022           91,132,356 34,425 88,893,548 1      
Ending balance at Sep. 30, 2022 161,154         $ 4 $ 0 $ 118 $ 0 851,824 (47,564) (643,228)
Beginning balance (in shares) at Dec. 31, 2022   173,074,510 34,425 88,893,548 1 173,074,510 34,425 88,893,548 1      
Beginning balance at Dec. 31, 2022 298,674         $ 8 $ 0 $ 118 $ 0 1,007,625 (38,898) (670,179)
Stockholders' Equity                        
Share-based compensation expense 7,948                 7,948    
Vesting of restricted stock (in shares)           860,213            
Vesting of restricted stock 0                      
Exercise of share options (in shares)           2,071            
Exercise of share options 4                 4    
Unrealized loss on foreign currency translation 5,104                   5,104  
Net loss (131,212)                     (131,212)
Ending balance (in shares) at Sep. 30, 2023   173,936,794 34,425 88,893,548 1 173,936,794 34,425 88,893,548 1      
Ending balance at Sep. 30, 2023 180,518         $ 8 $ 0 $ 118 $ 0 1,015,577 (33,794) (801,391)
Beginning balance (in shares) at Jun. 30, 2023           173,680,872 34,425 88,893,548 1      
Beginning balance at Jun. 30, 2023 229,336         $ 8 $ 0 $ 118 $ 0 1,012,709 (27,957) (755,542)
Stockholders' Equity                        
Share-based compensation expense 2,864                 2,864    
Vesting of restricted stock (in shares)           253,851            
Vesting of restricted stock 0                      
Exercise of share options (in shares)           2,071            
Exercise of share options 4                 4    
Unrealized loss on foreign currency translation (5,837)                   (5,837)  
Net loss (45,849)                     (45,849)
Ending balance (in shares) at Sep. 30, 2023   173,936,794 34,425 88,893,548 1 173,936,794 34,425 88,893,548 1      
Ending balance at Sep. 30, 2023 $ 180,518         $ 8 $ 0 $ 118 $ 0 $ 1,015,577 $ (33,794) $ (801,391)